BRPI0912489B8 - conjugado de nanotubos de carbono para inibir estruturas de infecção de patógenos em vegetais - Google Patents
conjugado de nanotubos de carbono para inibir estruturas de infecção de patógenos em vegetais Download PDFInfo
- Publication number
- BRPI0912489B8 BRPI0912489B8 BRPI0912489A BRPI0912489A BRPI0912489B8 BR PI0912489 B8 BRPI0912489 B8 BR PI0912489B8 BR PI0912489 A BRPI0912489 A BR PI0912489A BR PI0912489 A BRPI0912489 A BR PI0912489A BR PI0912489 B8 BRPI0912489 B8 BR PI0912489B8
- Authority
- BR
- Brazil
- Prior art keywords
- carbon nanotube
- plant pathogen
- pathogen infection
- inhibit plant
- nanotube conjugate
- Prior art date
Links
- 239000002041 carbon nanotube Substances 0.000 title abstract 4
- 229910021393 carbon nanotube Inorganic materials 0.000 title abstract 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 244000000003 plant pathogen Species 0.000 title abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 244000052769 pathogen Species 0.000 abstract 2
- 240000007154 Coffea arabica Species 0.000 abstract 1
- 244000166124 Eucalyptus globulus Species 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 244000046052 Phaseolus vulgaris Species 0.000 abstract 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract 1
- 241000607479 Yersinia pestis Species 0.000 abstract 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000016213 coffee Nutrition 0.000 abstract 1
- 235000013353 coffee beverage Nutrition 0.000 abstract 1
- 230000021615 conjugation Effects 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 210000000805 cytoplasm Anatomy 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/60—Isolated nucleic acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
conjugado de nanotubos de carbono para inibir estruturas de infecção de patógenos em vegetais. a presente invenção descreve a construção e uso de um sistema hibrido envolvendo a conjugação de nanotubos de carbono e oligonucleotideos. em seu aspecto mais geral relata processo e metodologia para a inibição ou controle de pragas e infecções de patógenos em vegetais, em especial, em culturas de importante interesse comercial tais como: feijão, soja, café e eucalipto, o conjugado oligonucleotídeo-nanotubos de carbono é utilizado como agente de internalização celular carreando uma seqúência específica de ácido nucléico, também denominado de oligonucleotídeo, de fora para dentro do citoplasma da célula do patógeno.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0912489A BRPI0912489B8 (pt) | 2009-12-30 | 2009-12-30 | conjugado de nanotubos de carbono para inibir estruturas de infecção de patógenos em vegetais |
| PCT/BR2010/000411 WO2011079356A1 (pt) | 2009-12-30 | 2010-12-14 | Conjugado de nanotubos de carbono para inibir estruturas de infecção de patógenos em vegetais |
| ARP100104959A AR079751A1 (es) | 2009-12-30 | 2010-12-27 | Conjugado de nanotubos de carbono para inhibir estructuras de infeccion de patogenos en vegetales |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0912489A BRPI0912489B8 (pt) | 2009-12-30 | 2009-12-30 | conjugado de nanotubos de carbono para inibir estruturas de infecção de patógenos em vegetais |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0912489A2 BRPI0912489A2 (pt) | 2012-02-28 |
| BRPI0912489B1 BRPI0912489B1 (pt) | 2018-03-06 |
| BRPI0912489B8 true BRPI0912489B8 (pt) | 2019-08-20 |
Family
ID=44226063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0912489A BRPI0912489B8 (pt) | 2009-12-30 | 2009-12-30 | conjugado de nanotubos de carbono para inibir estruturas de infecção de patógenos em vegetais |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR079751A1 (pt) |
| BR (1) | BRPI0912489B8 (pt) |
| WO (1) | WO2011079356A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250194590A1 (en) * | 2022-03-04 | 2025-06-19 | The Regents Of The University Of California | Compositions and methods for targeted delivery of chemicals and biomolecules to plants and fungi |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2724935B1 (fr) * | 1994-09-27 | 1996-12-20 | Centre Nat Rech Scient | Compositions nanoparticulaires contenant des derives nucleotidiques, leur preparation et leur emploi en therapeutique |
| WO1998004740A1 (en) * | 1996-07-29 | 1998-02-05 | Nanosphere Llc | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US8323976B2 (en) * | 2005-01-19 | 2012-12-04 | International Technology Center | Alterations utilizing nanoparticles |
| WO2007086883A2 (en) * | 2005-02-14 | 2007-08-02 | Sirna Therapeutics, Inc. | Cationic lipids and formulated molecular compositions containing them |
-
2009
- 2009-12-30 BR BRPI0912489A patent/BRPI0912489B8/pt not_active IP Right Cessation
-
2010
- 2010-12-14 WO PCT/BR2010/000411 patent/WO2011079356A1/pt not_active Ceased
- 2010-12-27 AR ARP100104959A patent/AR079751A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0912489B1 (pt) | 2018-03-06 |
| WO2011079356A1 (pt) | 2011-07-07 |
| AR079751A1 (es) | 2012-02-15 |
| BRPI0912489A2 (pt) | 2012-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2013039861A3 (en) | Engineered nucleic acids and methods of use thereof | |
| BR112015005674A2 (pt) | variantes e métodos de uso de hppd | |
| CA2796722C (en) | Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types | |
| BR112014001978A2 (pt) | proteínas variantes axmi205 e métodos para a utilização das mesmas | |
| BR112014022166A2 (pt) | gene da delta-endotoxina axmi345 e métodos para a sua utilização | |
| BR112014001909A2 (pt) | gene da toxina axmi270 e métodos para a sua utilização | |
| TW201121550A (en) | Antisense antiviral compound and method for treating influenza viral infection | |
| AR083309A1 (es) | Gen restaurador rf4 de esterilidad masculina citoplasmica (cms) tipo c del maiz, marcadores moleculares y su uso | |
| MX2019005671A (es) | Sustancias para direccionar diversos organos o tejidos seleccionados. | |
| BR112012004725A2 (pt) | Planta, métodos para controlar o crescimento de ervas daninhas, para produzir uma planta híbrida, para tratar a planta monocotiledônea, para selecionar uma planta transformada, e de reprodução, célula de planta, parte da planta, semente, produto, molécula de ácido nucleico isolado, recombinante ou mutagenizado, e, uso da molécula de ácido nucleico. | |
| Levina et al. | Knockdown of different influenza A virus subtypes in cell culture by a single antisense oligodeoxyribonucleotide | |
| BR112015026729A2 (pt) | Método para produção de uma biblioteca de moléculas de ligação de antígeno específica ao antígeno que tem estrutura de domínio de peptídeo; processo para a produção de uma molécula de ligação de antígeno específica ao antígeno; molécula de ligação de antígeno específica ao antígeno; proteína de fusão; ácido nucleico que codifica uma molécula de ligação de antígeno específica ao antígeno; construto de ácido nucleico; célula hospedeira; composição farmacêutica de uma molécula de ligação de antígeno específica ao antígeno; uso de uma molécula de ligação de antígeno específica ao antígeno; método de tratamento de uma doença em um paciente em necessidade de tratamento; método de ensaio para a presença de um analito alvo em uma amostra; método de formação de imagem de um local da doença em um indivíduo; método de diagnóstico de uma doença ou condição médica em um indivíduo | |
| MX2009004243A (es) | Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal. | |
| BR112014022034A2 (pt) | gene da toxina axmi335 de bacillus thuringiensis e métodos para a sua utilização | |
| WO2010111891A8 (zh) | 修饰的寡聚核酸分子及其制备方法和应用 | |
| Saadh | Epigallocatechin gallate (EGCG) combined with zinc sulfate inhibits Peste des petits ruminants virus entry and replication | |
| Dabrowska et al. | Efficacy of antiviral drugs against the omicron variant of SARS-CoV-2 | |
| BR112015022212A2 (pt) | sais estáveis de pentadecapeptídeo, processo para a preparação dos mesmos, uso dos mesmos na fabricação de preparações farmacêuticas e uso dos mesmos em terapia | |
| MX353828B (es) | Composicion que comprende acidos nucleicos de sistemas biologicos parasiticos, patogenicos o de malezas para inhibir y/o controlar el crecimiento de dichos sistemas. | |
| Lvov et al. | Evolution of H4, H5 influenza A viruses in natural ecosystems in Northern Eurasia (2000–2002) | |
| AR079751A1 (es) | Conjugado de nanotubos de carbono para inhibir estructuras de infeccion de patogenos en vegetales | |
| BR112015013625A2 (pt) | adjuvante de vacinação, preparação e vacinas contendo o mesmo | |
| Saraswat et al. | Engraulisin: A novel marine derived cell penetrating peptide with activity against drug resistant bacteria | |
| AR074725A1 (es) | Sal de maleato de 11-(2-pirrolidin-1-il-etoxi)-14,19- dioxa-5,7,26-triaza-tetraciclo(19.3.1.1 (2,6).1 (8,12) heptacosa-1(25),2 (26),3,5,8,10,12 (27),16,21,23-decaeno | |
| WO2014144442A3 (en) | Antisense molecules for treatment of staphylococcus aureus infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/12/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) REFERENTE A RPI 2461 DE 06/03/2018, QUANTO AO ITEM (72) NOME DO INVENTOR. |
|
| B24B | Patent annual fee: requirement for complementing annual fee |
Free format text: COMPLEMENTAR A RETRIBUICAO DA 9A ANUIDADE, DE ACORDO COM TABELA VIGENTE, REFERENTE A GUIA DE RECOLHIMENTO 29409161801488672. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AO DESPACHO 24.2, RPI 2538 DE 27-08-2019. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: REFERENTE AO DESPACHO 21.6 PUBLICADO NA RPI 2549 DE 2019-11-12 |